Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance

Seminars in Oncology
George A Calin, Carlo M Croce

Abstract

Chronic lymphocytic leukemia (CLL), the most frequent leukemia in adults in the Western world, is characterized by predominantly nondividing malignant CD5+ B cells overexpressing the anti-apoptotic Bcl2 protein. Significant familial aggregation with largely unknown mode of inheritance has been demonstrated. Until recently little else was known regarding the events leading to CLL initiation and progression. New findings support the view that CLL is a genetic disease where the main alterations occur at the level of transcriptional/post-transcriptional regulation of the malignant cells genome because of deregulations of a new class of genes named microRNAs (miRNAs). miRNA genes miR-15a and miR-16-1, located at 13q14.3, are frequently deleted and/or downregulated in patients with B-cell CLL. Both microRNAs negatively regulate Bcl2 at a post-transcriptional level and this repression is enough to induce apoptosis. Therefore, miR-15 and miR-16 are natural antisense Bcl2 interactors that could be used for therapy of Bcl2-overexpressing tumors. Furthermore, microRNA expression profiles can distinguish normal B cells from malignant B cells in CLL. A unique microRNA signature is associated with prognostic factors such as mutations in the ...Continue Reading

Citations

Feb 23, 2008·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Matthew Breen, Jaime F Modiano
Apr 23, 2013·Pathology Oncology Research : POR·Kun WangPeiyu Pu
Jun 6, 2009·Cell Death and Differentiation·R I AqeilanC M Croce
Sep 10, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Fumitaka TakeshitaTakahiro Ochiya
Oct 10, 2006·Oncogene·G A Calin, C M Croce
Oct 10, 2006·Oncogene·J M Cummins, V E Velculescu
Jan 24, 2007·Oncogene·K InoueD P Frazier
Jun 2, 2009·Médecine sciences : M/S·Yannick Ladeiro, Jessica Zucman-Rossi
Mar 26, 2008·Proceedings of the National Academy of Sciences of the United States of America·George A CalinCarlo M Croce
May 7, 2010·Nucleic Acids Research·Yu-Long HuWei-Fang Shen
Dec 22, 2012·Leukemia Research and Treatment·Yao YuanElizabeth Raveche
Dec 7, 2007·The Journal of Clinical Investigation·Alan M Gewirtz
Nov 13, 2008·PloS One·Melissa Piper HunterClay B Marsh
May 21, 2010·PloS One·Jeannie L TeJoshua O Ojwang
Apr 4, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ranjan J Perera, Animesh Ray
Oct 18, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Helena UrbankovaMarie Jarosova
Aug 1, 2008·Nutrition Reviews·Cindy D Davis, Sharon A Ross
Oct 28, 2015·Expert Review of Clinical Immunology·Francesco MannavolaFranco Silvestris
Jul 1, 2007·Expert Opinion on Drug Discovery·Yves St-Pierre
Jun 13, 2013·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Michela Garofalo, Carlo M Croce
Dec 24, 2015·Frontiers in Medicine·Cristina Sorina CătanăIoana Berindan-Neagoe
Sep 29, 2009·Mechanisms of Ageing and Development·Guorong LiPedro Gonzalez
Jun 13, 2009·Critical Reviews in Oncology/hematology·Haifeng ZhaoRenchi Yang
May 2, 2009·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Kwang-Hyuck LeeAnirban Maitra
Oct 1, 2008·Biochemical and Biophysical Research Communications·Yaroslav IlnytskyyOlga Kovalchuk
Feb 23, 2008·Seminars in Cancer Biology·Enikö SonkolyAndor Pivarcsi
Oct 27, 2007·British Journal of Haematology·Christoph PlassAlbert de la Chapelle
Jan 30, 2009·Journal of Cellular and Molecular Medicine·E Sonkoly, A Pivarcsi
Sep 27, 2006·Genes, Chromosomes & Cancer·Claudia SchochTorsten Haferlach
Oct 15, 2010·Journal of Cellular Physiology·Yexin Zhou, Jianping Xie
Aug 12, 2014·CA: a Cancer Journal for Clinicians·Ioana Berindan-NeagoeGeorge A Calin
Apr 20, 2010·American Journal of Obstetrics and Gynecology·David E CohnKimberly E Resnick
Sep 13, 2013·Tuberculosis·Harapan HarapanDaniela M Cirillo
Apr 5, 2013·PloS One·Esma OzhunerTurgay Unver

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
A CimminoCarlo M Croce
Nature Reviews. Cancer
Aurora Esquela-Kerscher, Frank J Slack
Proceedings of the National Academy of Sciences of the United States of America
G A CalinCarlo M Croce
© 2022 Meta ULC. All rights reserved